COVID-19 Updates: What We're Doing to Keep You Safe » COVID-19 Resources » Updated Visitor Policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Pharmacokinetics of Ketamine in Infants and Children
Trial ID or NCT#
Status
NOT RECRUITING
Purpose
Dosing of medications is based on the plasma level achieved with a given dose and how long the medicine remains in the body. This study is called pharmacokinetics-that is, what the body does to the medication. Ketamine is an intravenous medication used for anesthesia and sedation in children. However the pharmacokinetics of Ketamine has not been systematically studied. We propose to study the pharmacokinetics of ketamine in different age groups of children ranging from infants to teenagers.
Official Title
Pharmacokinetics of Ketamine in Infants and Children
Eligibility Criteria
- - Term infants (38 weeks gestation)and infants and children up to age 18 years. - Patients who require procedures that necessitate at least 8 hours in the hospital and those being admitted after procedure will be eligible to participate. - Patients who will receive ketamine as part of their standard anesthesia regimen.
- - Preterm neonates - Liver Disease - Kidney disease - Heart failure - Sepsis - Patients receiving anticonvulsants or barbiturates
Investigator(s)
Contact us to find out if this trial is right for you.
CONTACT
Archana Verma
(650) 721-1713
View on ClinicalTrials.gov
About this Clinical Trial
Pharmacokinetics of Ketamine in Infants and Children
Your Message Will Go To
Archana Verma6507211713